Immunolocalization of full-length NK1 tachykinin receptors in human tumors

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 9, 2006, Pages 1015-1020

  Schulz, Stefan ^a   Stumm, Ralf ^a   Röcken, Christoph ^a   Mawrin, Christian ^a   Schulz, Solveig ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Antibody; Immunocytochemistry; Neoplasm; NK1 receptor; Substance P; Tachykinin; Western blot

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; PARAFFIN; SUBSTANCE P;

ADSORPTION; ANTIBODY SPECIFICITY; ARTICLE; BINDING SITE; BREAST CARCINOMA; CANCER; CANCER DIAGNOSIS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR WEIGHT; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANTIBODIES; ANTIBODY SPECIFICITY; CELL LINE; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; PARAFFIN EMBEDDING; PEPTIDE FRAGMENTS; RECEPTORS, NEUROKININ-1;

EID: 33748053334     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A6966.2006     Document Type: Article

References (25)

1. Breeman WA, VanHagen MP, Visser-Wisselaar HA, van der Pluijm ME, Koper JW, Setyono-Han B, Bakker WH, et al. (1996) In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA- Arg1]substance P. J Nucl Med 37:108-117
2. Ehlers RA, Kim S, Zhang Y, Ethridge RT, Murrilo C, Hellmich MR, Evans DB, et al. (2000) Gut peptide receptor expression in human pancreatic cancers. Ann Surg 231:838-848
3. Fong TM, Anderson SA, Yu H, Huang RR, Strader CD (1992) Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol 41:24-30
4. Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, et al. (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Invest 83:731-742
5. Fukuhara S, Shimizu M, Matsushima H, Mukai H, Munekata E (1998) Signaling pathways via NK1 receptors and their desensitization in an AR42J cell line. Peptides 19:1349-1357
6. Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61:786-792
7. Johnson CL, Johnson CG, Stauderman KA, Buck SH (1991) Characterization of substance P receptors in human astrocytoma cells. Ann NY Acad Sci 632:410-412
8. Koon HW, Zhao D, Na X, Moyer MP, Pothoulakis C (2004) Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J Biol Chem 279:45519-45527
9. Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56:4983-4991
10. Maggi CA, Patacchini R, Rovero P, Giachetti A (1993) Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol 13:23-93
11. Mundschenk J, Unger N, Schulz S, Hollt V, Steinke R, Lehnert H (2003) Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab 88:5150-5157
12. Munoz M, Perez A, Rosso M, Zamarriego C, Rosso R (2004) Antitumoral action of the neurokinin-1 receptor antagonist L-733 060 on human melanoma cell lines. Melanoma Res 14:183-188
13. Munoz M, Rosso M, Perez A, Covenas R, Rosso R, Zamarriego C, Piruat JI (2005) The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides 39:427-432
14. Palma C, Bigioni M, Irrissuto C, Nardelli F, Maggi CA, Manzini S (2000) Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft. Br J Cancer 82:480-487
15. Palma C, Maggi CA (2000) The role of tachykinins via NK1 receptors in progression of human gliomas. Life Sci 67:985-1001
16. Palma C, Nardelli F, Manzini S (1999a) Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists. Eur J Pharmacol 374:435-443
17. Palma C, Nardelli F, Manzini S, Maggi CA (1999b) Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors. Br J Cancer 79:236-243
18. Patel HJ, Ramkissoon SH, Patel PS, Rameshwar P (2005) Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc Natl Acad Sci USA 102:17436-17441
19. Pfeiffer M, Koch T, Schroder H, Klutzny M, Kirscht S, Kreienkamp HJ, Hollt V, et al. (2001) Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 276:14027-14036
20. Reubi JC, Macke HR, Krenning EP (2005) Candidates for peptide receptor radiotherapy today and in the future. J Nucl Med 46(suppl 1):67-75S
21. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865-1874
22. Schulz S, Rocken C, Mawrin C (2005) Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues. J Clin Endocrinol Metab 90:6149-6155
23. Schulz S, Rocken C, Mawrin C, Weise W, Hollt V (2004) Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clin Cancer Res 10:8235-8242
24. Singh D, Joshi DD, Hameed M, Qian J, Gascon P, Maloof PB, Mosenthal A, et al. (2000) Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc Natl Acad Sci USA 97:388-393
25. Winkler A, Papsdorf G, Odarjuk J, Siems WE, Fickel J, Melzig MF (1995) Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. Eur J Pharmacol 291:51-55